IL18 and depressive symptom measurement: A 2023 large-scale two-sample MR study analyzing 41 inflammation-related factors across over 130,000 depression cases found that only a few cytokines, such as IL-18, IL-1β, and RANTES, exhibited protective associations with depression risk (19).